Anti-Ischemic Activity of n-Tyrozol under Conditions of Repeated Transient Myocardial Ischemia in Rats

Area of Science:

• Cardiology
• Pharmacology
• Ischemic Heart Disease Research

Background:

• Myocardial ischemia, particularly transient episodes, poses a significant risk for cardiac arrhythmias and long-term damage.
• Developing effective therapeutic agents to mitigate ischemia-reperfusion injury is a critical area of cardiovascular research.

Purpose of the Study:

• To investigate the anti-ischemic properties of n-tyrozol.
• To evaluate the efficacy of n-tyrozol in preventing cardiac arrhythmias during and after transient myocardial ischemia.

Main Methods:

• A rat model of repeated transient myocardial ischemia was induced by occluding the left coronary artery (5x3 min).
• N-tyrozol was administered intraperitoneally daily for 4 days prior to ischemia induction.
• Electrocardiogram (ECG) changes, including ST elevation and recovery, were monitored.
• The incidence and duration of ventricular arrhythmias (ventricular tachycardia and fibrillation) were assessed during reperfusion.

Main Results:

• N-tyrozol administration significantly reduced ST segment elevation on ECG, indicating a protective effect against ischemic injury.
• The compound promoted a more complete recovery of ECG parameters during the reperfusion phase.
• N-tyrozol markedly decreased the risk of developing ventricular fibrillation.
• The duration of tachyarrhythmia episodes, such as ventricular tachycardia and fibrillation, was significantly shortened.

Conclusions:

• N-tyrozol exhibits potent anti-ischemic activity in a preclinical model of repeated transient myocardial ischemia.
• The findings suggest that n-tyrozol can effectively reduce cardiac electrical instability and arrhythmias associated with ischemia-reperfusion.
• N-tyrozol represents a promising therapeutic candidate for managing acute myocardial infarction and preventing associated complications.